It was found that the levels of CA125, HE4, and ROMA were remarkably higher in the observation group than those in the control group, implying that patients with ovarian cancer exhibit obviously raised levels of serum CA125 and HE4 levels and an abnormal ROMA level. The gene discussed is WFDC2; the disease is ovarian cancer.